APA (7th ed.) Citation

Pathil-Warth, A., Liebisch, G., Okun, J. G., Chamulitrat, W., Schmitz, G., & Stremmel, W. (2015). Ursodeoxycholyl lysophosphatidylethanolamide modifies aberrant lipid profiles in NAFLD. European journal of clinical investigation, 45(9), . https://doi.org/10.1111/eci.12486

Chicago Style (17th ed.) Citation

Pathil-Warth, Anita, Gerhard Liebisch, Jürgen G. Okun, Walee Chamulitrat, Gerd Schmitz, and Wolfgang Stremmel. "Ursodeoxycholyl Lysophosphatidylethanolamide Modifies Aberrant Lipid Profiles in NAFLD." European Journal of Clinical Investigation 45, no. 9 (2015). https://doi.org/10.1111/eci.12486.

MLA (9th ed.) Citation

Pathil-Warth, Anita, et al. "Ursodeoxycholyl Lysophosphatidylethanolamide Modifies Aberrant Lipid Profiles in NAFLD." European Journal of Clinical Investigation, vol. 45, no. 9, 2015, https://doi.org/10.1111/eci.12486.